Back

Pharma

4th Annual Aseptic Processing Summit

  • 19th – 20th November 2020
  • Germany flag Germany Frankfurt
  • Radisson Blu Hotel Franklinstraße 65, 60486

At this summit, during the two days of insightful case studies, participants will be given the opportunity to network with peers involved in pharmaceutical manufacturing, aseptic fill and finish, quality control, engineering, and container development.  

Many more interesting and up-to-date topics will be included in this year’s program, so stay tuned and see you in November 2020 in Frankfurt! 

Read more

About

Vonlanthen Group is pleased to invite you to the 4th Annual Aseptic Processing Summit scheduled on November 19th – 20th, 2020 in Frankfurt, Germany. At this summit, participants will be given the opportunity to discourse and to network with peers involved in pharmaceutical manufacturing, aseptic fill and finish, quality control, engineering, and container development.

Key topics in Aseptic Processing will be discussed by some of the industry’s leading lights. This conference will give you a broad overview of current changes in the European regulations, modern technical trends, emerging technologies and innovations. We are delighted to give you this opportunity to participate at this Summit. We look forward to welcoming you in Frankfurt in November!

Who Should Attend

Chief Executives, Directors, Vice Presidents, Heads, Leaders, Senior Managers, Scientists, Chemists, Engineers and Fellows specialising in:

  • Bioprocess Research
  • and Development
  • Biotechnology
  • Container Development
  • CMC
  • Drug Development
  • Engineering
  • Fill and Finish
  • Freeze-Drying
  • Formulation
  • Licensing
  • Lyophilisation
  • Medical Devices
  • Nanomaterials
  • Parenterals
  • Packaging and Labelling
  • Pharmaceutical Process and Technology
  • Process Monitoring and Control
  • Process Analytics
  • Product Innovation
  • Packaging
  • QA/QC
  • R&D
  • Risk Management
  • Regulatory Affairs
  • Stability
  • Standardisation Science
  • Sterilisation
  • Vaccine/Antibody/Cell Manufacturing
  • Validation

Great networking opportunities!

REQUEST A BROCHURE

To request an agenda for this Summit, please complete the details below. We will send you the agenda via email.

Key Practical Learning Points

  • How ready are your cleanrooms for the Annex 1 updates?
  • Implementation of quality risk management
  • Final fill with SU Equipment
  • ADC/HPAPI aseptic processing fill and finish
  • Robotics in aseptic processing
  • Gloveless Isolators and dose control
  • The Evolution of Aseptic Technologies
  • Occupational safety requirements
  • Multi-Product facilities
  • Challenges for manufacturers in cell and gene therapy production systems

Great networking opportunities!

Richard Denk, CH

Senior Consultant, Aseptic Processing & Containment

Skan AG

Richard Denk has studied mechanical engineering and did an examination on experts of GMP, qualification and validation, pharmaceutical auditing, phar­maceutical engineering, quality control at the University of Applied Sciences in Albstadt/Sigmaringen Germany. Richard works at SKAN AG, headquartered in Allschwil, as the head of sales containment. He founded the expert Con­tainment Group of the ISPE DACH eight years ago. The Containment Group published the Containment Manual in September 2015. Richard has spent nearly 20 years working with highly active/highly hazardous substances and has developed the containment pyramid.

Walid El Azab, BE

Industrial Pharmacist, Qualified Person / Senior Manager Technical Services

STERIS Corporation

Walid El Azab is an industrial pharmacist, a qualified person and a Lean Six Sigma green belt. He is a technical services manager for STERIS Life Sciences. He provides technical support related to cleaning, disinfectants, sterility assurance and process validation. Finally, he leads audits at manu­facturer sites and workshops to improve processes and inspection readiness level. Walid is a lecturer at a pharmacy and medicine university. He has published different articles and book chapters, and he is also part of working groups on sterilisation and EU GMP Annex 1 guideline revision. He is a plan­ning committee member of the Annual PDA Conference on Pharmaceutical Microbiology (12th and 13th editions), and part of the editorial committee of the PDA Letter. Walid is an observer member of the ISPE Belgium affiliate board. Finally, he is secretary of the Belgium Qualified Person Association.

Dr. Mauro Giusti, IT

Advisor, Site External Network

Eli Lilly Italia

Dr. Mauro Giusti holds a Master's Degree in Chemistry at the University of Florence and he is Board Certified by National Chemist association.

After completion of mandatory military service as an Army officer, he joined Eli Lilly at the Italy manufacturing plant site in 1988.  Over the 32 years with Eli Lilly, Dr. Giusti has covered several positions within the Lilly Manufacturing organization (Regulatory, Technical Services, Project Management, Quality Control, Quality Assurance, Production of oral and parenteral products, Technical Director/Qualified Person, Six Sigma Champion. Manufacturing Science and Technology, Manufacturing Procurement), dealing both with Lilly manufacturing plants as well as with Contract manufacturing in the Europe/Africa/Asia.

Among the several experiences with Lilly, he has worked approximately 5 years outside of Italy, both in United States (2.5 yrs, from 1992 to 1994) and in United Kingdom (2.5 yrs, from 1997 to 1999).

Since late 2003, with the Lilly Italia mission change from Sterile and Oral cephalosporin to Biotech products,  he has had responsibility for Lilly Italy TSMS (Technical Svcs/Mfg Science Department), with responsibility for Metrology, C&Q of facilities, utilities, and equipment, Sterility Assurance, Process Validation, set-up of new manufacturing processes and of new manufacturing technology for Biotech products, including automatic assembly of disposable Ins. pens and Autoinjectors. In September 2009 he also added to his TSMS duties,  the responsibility for Manufacturing Sourcing and Vendor Management.

In September 2019 he has taken a new role, as Advisor, Site External Network, dealing with external entities linked to the Lilly Sesto Manufacturing site (especially Universities) and leading a Lilly Global project for improvement of technical capabilities in Parenteral Manufacturing.

For more than 12 years he has served as a member of the Italy Chapter of PDA, with several participations to national and international forum both as a speaker and as chairman.

Henrietta Vinnerås, SWE

Sr. Manager Microbiology & Aseptic Technique / Global Manufacturing Pharmaceuticals

Fresenius Kabi

Mrs. Vinnerås has been with Fresenius Kabi since 2017, and previous to that since 2000 she worked for pharmaceutical and medical device companies such as Abbott and Pfizer within different quality departments and holding various management responsibilities and positions. Recently, as an associated senior quality consultant at ÅF Life Science, she had assignments within the areas of quality assurance, risk management, validation and education at clients such as GE Healthcare, Thermo Fisher Scientific, Fresenius Kabi and smaller life science companies. Currently, Henrietta is part of a global compe­tence center within Fresenius Kabi, supporting the companys’ pharmaceutical manufacturing operations worldwide by establishing global corporate proce­dures, performing on-site assessments, education and training, trouble shoot­ing, root cause investigations, CAPAs and continuous improvement projects; specifically within the areas of microbiology and aseptic technique.

Dr. Thomas Schwarz, CH

Head of Strategic Planning & PMO / NTO Aseptics

Novartis

Thomas Schwarz has a PhD in chemistry and an executive MBA. He joined Aventis in 1999 in Frankfurt, where he worked in recombinant insulin pro­duction. He has worked at Novartis since 2006 in a variety of functions in­cluding process manager of sterile manufacturing, plant manager of biotech in the US and QA/QV team leader. He is currently the head of strategic plan­ning for aseptics, which includes nine drug product sites around the globe.

Dieter Bachmann, US

Director Aseptic Processing

Johnson & Johnson

Dr. Robert Liebner, DE

Principal Scientist

Merck Healthcare KGaA

Principal Scientist for Parenteral Process Development in Pharmaceutical Technologies at Merck Healthcare KGaA in Darmstadt, Germany.

Robert is a pharmacist by training and holds a PhD in Pharmaceutical Technology from the Ludwig-Maximilians University in Munich, Germany. At the LMU he gained profound knowledge in the field of formulation development of therapeutic protein-polymer conjugates. He joined the pharmaceutical industry in 2014 as a compliance expert at Sanofi-Aventis Deutschland GmbH (Frankfurt am Main, Germany) and was responsible for the industrialization of parenteral late stage projects as well as process optimization of marketed parenteral products. In 2017, he joined the Merck Healthcare KGaA (Darmstadt, Germany) in the role of a principal scientist for parenteral DP development. Additionally, he represents the head of manufacturing for the construction of a novel high containment GMP pilot plant for sterile DP manufacturing where cutting-edge single-use technology as well as latest regulatory expectations will be implemented. 

Matthias Angelmaier, DE

Global Product Manager Isolator and Process Technology

Syntegon

Matthias Angelmaier has a bachelor’s degree in industrial and mechanical engineering as well as a master’s degree in business development. He joined Syntegon Technology GmbH in 2009. During his first 3 years, he was a project manager for handling complex customer projects. Since 2012, he is the globally responsible product manager for barrier systems, isolator and process technology. His expertise includes process engineering, sterilization, bio-decontamination, aseptic and high-potent Isolator applications, glove testing systems as well as topics related to advanced aseptic processing. He is a frequent speaker on international symposia and conferences including organizations like ISPE and PDA

Dr. Robert W. Lee, US

President, CDMO division

Lubrizol Life Science Health

Dr. Lee is responsible for product and business development along with providing strategic direction. Before joining LLS Health, Rob held senior management positions at Novavax, Inc., Lyotropic Therapeutics, Inc., and Imcor Pharmaceutical Co. He holds BSs in Biology and Chemistry from the University of Washington and a PhD in Physical Bioorganic Chemistry from the University of California, Santa Barbara. Rob has published more than three dozen articles and five book chapters plus holds 11 issued patents and 15 provisional or PCT patent applications. He has over 30 years of experience in pharmaceutical research and development of both therapeutic drugs and diagnostic imaging agents. Rob maintains strong academic ties, including an appointment as Adjunct Associate Professor of Pharmaceutical Chemistry at the University of Kansas in the early 1990s, serving as a reviewer for both the International Journal of Pharmaceutics and Journal of Pharmaceutical Sciences, and serving on the Editorial Board for the Journal MOJ Bioequivalence & Bioavailability, The Scientific Pages of Nanotechnology, and The Journal of Analytical and Pharmaceutical Research.

Sebastian Scheler, AT

Founder/CEO and Lead Psychologist

Innerspace – The Deep Training Company

Sebastian Scheler (born 1987) is a qualified psychologist and expert trainer. As CEO and Lead Psychologist (since 2017) at Innerspace - The DeepTraining Company, he is not only responsible for company management moreover for the global business development and implementation of deep training products in the pharmaceutical industry. As an expert in training transfer and human error analysis, he is also a speaker at various specialist events.

Richard Denk, CH

Senior Consultant, Aseptic Processing & Containment

Skan AG

Walid El Azab, BE

Industrial Pharmacist, Qualified Person / Senior Manager Technical Services

STERIS Corporation

Dr. Mauro Giusti, IT

Advisor, Site External Network

Eli Lilly Italia

Henrietta Vinnerås, SWE

Sr. Manager Microbiology & Aseptic Technique / Global Manufacturing Pharmaceuticals

Fresenius Kabi

Dr. Thomas Schwarz, CH

Head of Strategic Planning & PMO / NTO Aseptics

Novartis

Dieter Bachmann, US

Director Aseptic Processing

Johnson & Johnson

Dr. Robert Liebner, DE

Principal Scientist

Merck Healthcare KGaA

Matthias Angelmaier, DE

Global Product Manager Isolator and Process Technology

Syntegon

Dr. Robert W. Lee, US

President, CDMO division

Lubrizol Life Science Health

Sebastian Scheler, AT

Founder/CEO and Lead Psychologist

Innerspace – The Deep Training Company

What our
participants
are saying

"Great speakers & exemplary knowledge sharing across the industry!"

1
2
3
4
5

Wolfgang Oitzinger

Takeda

"I ( and many others from the conference) think this is the best European conference on Aseptic Filling technology. Very interesting conference"

1
2
3
4
5

Enrico Zanetti

Swissfillon AG


"It was a pleasure to give a speech at the 3rd Annual Aseptic Processing Summit in Vienna! Great exchange of expertise and very wide networking across Pharma & Biopharma Companies. Thanks to you for the invitation!"

1
2
3
4
5

Nicola Rutigliani

Merck Italia

"It was a great conference; great information sharing across all groups. Over 100 people."

1
2
3
4
5

Christa Myers

CRB

"Thank you Dana and the rest of the Vonlanthen team for a well-organized summit in Vienna – and an extended thank you to all speakers and participants for all the good discussions and networking during the two days we had together!"

1
2
3
4
5

Henrietta Vinnerås

Fresenius Kabi